BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 24810645)

  • 1. Chronic hepatitis B virus infection: epidemiology, prevention, and treatment in China.
    Yu R; Fan R; Hou J
    Front Med; 2014 Jun; 8(2):135-44. PubMed ID: 24810645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology study of HBV genotypes and antiviral drug resistance in multi-ethnic regions from Western China.
    Zhang Q; Liao Y; Chen J; Cai B; Su Z; Ying B; Lu X; Tao C; Wang L
    Sci Rep; 2015 Nov; 5():17413. PubMed ID: 26612031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B: changing epidemiology and interventions.
    Nannini P; Sokal EM
    Arch Dis Child; 2017 Jul; 102(7):676-680. PubMed ID: 27986700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to control highly endemic hepatitis B in Asia.
    Shan S; Cui F; Jia J
    Liver Int; 2018 Feb; 38 Suppl 1():122-125. PubMed ID: 29427490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [China's hepatitis B burden and expectation on 40 years of trials and tribulations].
    Cai DC; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jan; 27(1):3-5. PubMed ID: 30685915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the prevalence of drug-resistant hepatitis B virus in patients with antiviral therapy failure in a Chinese tertiary referral liver centre (2010-2014).
    Meng T; Shi X; Gong X; Deng H; Huang Y; Shan X; Shan Y; Huang A; Long Q
    J Glob Antimicrob Resist; 2017 Mar; 8():74-81. PubMed ID: 28017671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of hepatitis B virus (HBV) genotypes for the disease and treatment outcome among patients with chronic hepatitis B in Serbia.
    Milosevic I; Delic D; Lazarevic I; Pavlovic IP; Korac M; Bojovic K; Jevtovic D
    J Clin Virol; 2013 Sep; 58(1):54-8. PubMed ID: 23838671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic distribution, virologic and clinical characteristics of hepatitis B virus genotypes in China.
    Zeng G; Wang Z; Wen S; Jiang J; Wang L; Cheng J; Tan D; Xiao F; Ma S; Li W; Luo K; Naoumov NV; Hou J
    J Viral Hepat; 2005 Nov; 12(6):609-17. PubMed ID: 16255762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis B in Asia-new insights from the past decade.
    Chan HL; Jia J
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():131-7. PubMed ID: 21199524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline on prevention and treatment of chronic hepatitis B in China (2005).
    ;
    Chin Med J (Engl); 2007 Dec; 120(24):2159-73. PubMed ID: 18167196
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of chronic hepatitis B: experience from China.
    Sun J; Hou JL
    J Viral Hepat; 2010 Mar; 17 Suppl 1():10-7. PubMed ID: 20586929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease burden of chronic hepatitis B and complications in China from 2006 to 2050: an individual-based modeling study.
    Zheng Y; Wu J; Ding C; Xu K; Yang S; Li L
    Virol J; 2020 Aug; 17(1):132. PubMed ID: 32859216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in hepatitis B virus resistance to nucleoside/nucleotide analogues in North China from 2009-2016: A retrospective study.
    Guo X; Wu J; Wei F; Ouyang Y; Li Q; Liu K; Wang Y; Zhang Y; Chen D
    Int J Antimicrob Agents; 2018 Aug; 52(2):201-209. PubMed ID: 29654894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profile, spectrum and significance of hepatitis B virus genotypes in chronic HBV-infected patients in Yunnan, China.
    You J; Sriplung H; Chongsuvivatwong V; Geater A; Zhuang L; Huang JH; Chen HY; Yu L; Tang BZ
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):271-9. PubMed ID: 18522881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of vaccination and antiviral therapy on hepatitis B and hepatitis D epidemiology.
    Goyal A; Murray JM
    PLoS One; 2014; 9(10):e110143. PubMed ID: 25313681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Distribution of hepatitis B virus genotypes in patients with chronic hepatitis B virus infection among 12 cities in China].
    Gao JW; Li YJ; Zhuang H; Li J; Wang J; Dong QM; Chen YJ; Niu JQ; Ma WM; Zhao W; Zhao BA; Zhong JQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Apr; 28(4):315-8. PubMed ID: 17850692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of hepatitis B virus genotype changes in patients with chronic hepatitis B infection on tenofovir therapy.
    Chauhan R; Singh AK; Rooge S; Varshney A; Kumar M; Sarin SK
    J Med Virol; 2016 Aug; 88(8):1364-75. PubMed ID: 26858138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of hepatitis B virus genotypes/subgenotypes in 1,301 patients with chronic hepatitis B in North China.
    Li XD; Wang L; Liu Y; Xu ZH; Dai JZ; Li L; Yao ZT; Xin SJ; Zhao JM; Xu DP
    Chin Med J (Engl); 2011 Dec; 124(24):4178-83. PubMed ID: 22340383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the way towards the eradication of chronic hepatitis B.
    Ren H
    J Viral Hepat; 2019 Jul; 26 Suppl 1():3-4. PubMed ID: 31380587
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular virology in chronic hepatitis B: genotypes.
    Wong GL; Chan HL
    Hosp Med; 2005 Jan; 66(1):13-6. PubMed ID: 15686160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.